Presidential seal

CCR scientists receive the Presidential Early Career Award for Scientists and Engineers

Jul 11, 2019

John Brognard, Ph.D., Investigator in the Laboratory of Cell and Developmental SignalingRomina Goldszmid, Ph.D., Investigator in the Cancer and Inflammation Program, and Anish Thomas, M.D., Investigator in the Developmental Therapeutics Branch, are recipients of the Presidential Early Career Award for Scientists and Engineers (PECASE). The PECASE is the highest honor bestowed by the United States Government to outstanding scientists and engineers who are beginning their independent research careers and who show exceptional promise for leadership in science and technology. Established in 1996, the PECASE acknowledges the contributions scientists and engineers have made to the advancement of science, technology, engineering and mathematics education and to community service as demonstrated by scientific leadership, public education and community outreach. Read more...

Jonathan Hernandez

Jonathan Hernandez discusses surgical oncology with Behind the Knife podcast

Jul 2, 2019

Jonathan Hernandez, M.D., Investigator in the Surgical Oncology Program, was recently featured in a Behind the Knife podcast. During the episode, Dr. Hernandez discussed the surgical oncology match process and his research on ex vivo tissue preservation to study tumors. The full podcast is available online. Read more...

Conquer Cancer logo

CCR fellows receive Conquer Cancer Foundation of ASCO Young Investigator Awards

Jun 11, 2019

Congratulations to Vid Leko M.D., Lekha Mikkilineni, M.D., and Chen Zhao, M.D., for receiving the Conquer Cancer Foundation of ASCO Young Investigator Award (YIA). The YIA provides funding to promising investigators to encourage and promote quality research in clinical oncology. The purpose of this grant is to fund physicians during the transition from a fellowship program to a faculty appointment. Read more...

Atlantic Live logo

Nirali Shah and Lori Wiener participate in AtlanticLIVE summit

Jun 6, 2019

Nirali Shah, M.D., MHSc, Investigator in the Pediatric Oncology Branch (POB), and Lori Wiener, Ph.D., DCSW, LCSW-CStaff Scientist in POB, recently participated in an AtlanticLIVE summit called Children and Cancer. During the event, they discussed their work developing immunotherapies and psychosocial standards of care for children with cancer. Watch their respective sessions here and here. Read more...

Udo Rudloff headshot

Udo Rudloff discusses germline mutations with Bloomberg podcast

Jun 6, 2019

Udo Rudloff, M.D., Ph.D., Investigator in the Pediatric Oncology Branch, was recently featured on Bloomberg’s Prognosis podcast.During the episode, “Should We Be Scared of Our DNA?," Dr. Rudloff discussed CDH1 germline mutations and risk of hereditary diffuse gastric cancer (HDGC) in an evolving environment, which he is currently studying as part of the Rare Tumor Initiative. The full podcast is available online. Read more...

Nataliya Buxbaum

Nataliya Buxbaum wins Magnetic Moments video competition

May 22, 2019

Nataliya P. Buxbaum, M.D., Assistant Clinical Investigator in the Experimental Transplantation and Immunology Branch, was named the overall winner of the International Society for Magnetic Resonance in Medicine’s Magnetic Moments Competition. The competition is designed for investigators to use video to describe their MRI-related research for a general audience. Dr. Buxbaum’s video describes her research using tracers to better and more safely image tumors.  Read more...

Julius Strauss

Julius Strauss discusses promising immunotherapy drug for patients with HPV-related cancers

May 13, 2019

Julius Strauss, M.D., Assistant Research Physician in the Laboratory of Tumor Immunology and Biology, discussed a promising immunotherapy drug for patients with HPV-related cancers in a recent NCI Cancer Currents blog post. According to results from a phase 1 clinical trial, 33 percent of the 36 patients on the trial with HPV-positive tumors responded to the drug, and four of the responses lasted longer than 18 months. “This drug is a promising agent for patients with HPV-related cancers and may potentially benefit these patients more than traditional checkpoint therapies,” said Dr. Strauss. Read more...

Screenshot of video on YouTube

Brid Ryan cohosts NCI Minority Health Month Facebook Live

May 13, 2019

The National Cancer Institute hosted a Facebook Live entitled, A Dialogue on Cancer Disparities, Prevention, and Research.”The event featured Brid M. Ryan, Ph.D., M.P.H., Investigator in the Laboratory of Human Carcinogenesis, as well as Worta McCaskill-Stevens, M.D., M.S., from the Division of Cancer Prevention, and Christina Dieli-Conwright, Ph.D., M.P.H., from the University of Southern California. They discussed cancer disparities and the work being done to help reduce them. Read more...

Marston Linehan

Marston Linehan receives 2019 Urology Care Foundation Distinguished Mentor award

May 7, 2019

Marston Linehan, M.D., Chief of the Urologic Oncology Branch, has received the 2019 Urology Care Foundation Distinguished Mentor award. The award recognizes Dr. Linehan’s outstanding track record of fostering the next generation of urologic researchers by providing excellent training and guidance to early-career investigators.  Read more...

Elaine Jaffe

Elaine Jaffe receives the 2019 USCAP Board’s Distinguished Pathologist award

Apr 11, 2019

Elaine Jaffe, M.D., Senior Investigator in the Laboratory of Pathology, has received the 2019 United States and Canadian Academy of Pathology (USCAP) Board’s Distinguished Pathologist award. The award recognizes an individual for making major contributions to pathology over the years.  Read more...